doxorubicin-cobalamin bioconjugates (Inflabloc)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namedoxorubicin-cobalamin bioconjugates (Inflabloc)
Drug Alias Namedoxorubicin-cobalamin bioconjugates (MantiCore/University of Utah)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Utah
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMantiCore Pharmaceuticals IncInflabloc Pharmaceuticals IncThe University Of Utah
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A